Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.34 |
| ▸ | TMPRSS15 | P98073 | 9/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7196430 | 0.74 | SMN1; SMN2 (0.41) | LMNAHTTRAB9AADORA3 | |
| SCHEMBL23817403 | 0.74 | CES2 (0.42) | — | |
| SCHEMBL23382999 | 0.74 | NPSR1 (0.40) | LMNAMAPK1ADORA3 | |
| SCHEMBL23383183 | 0.74 | LMNA (0.35) | NOTUMLMNAMAPK1HTTRAB9A | |
| SCHEMBL23519039 | 0.74 | NOTUM (0.45) | NOTUMLMNAMAPK1HTTRAB9A | |
| SCHEMBL23383181 | 0.73 | LMNA (0.34) | NOTUMLMNAMAPK1HTTRAB9A | |
| SCHEMBL23382992 | 0.73 | SMN1; SMN2 (0.39) | LMNAMAPK1HTTRAB9AADORA3 | |
| SCHEMBL23817401 | 0.73 | TSHR (0.42) | — | |
| SCHEMBL3671321 | 0.72 | LMNA (0.46) | LMNAMAPK1 | |
| SCHEMBL23382829 | 0.71 | FFAR1 (0.36) | LMNAMAPK1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127225-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127225-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | CACNA1F, SLC6A5, IDUA | NOTUM 399/4885LMNA 942/4885MAPK1 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.